Market Overview

Aerpio Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC

Share:

Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company
focused on advancing first-in-class treatments for ocular diseases,
today announced that Chief Executive Officer, Stephen Hoffman, M.D.,
Ph.D., will present at the 20th Annual Rodman & Renshaw
Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC,
on Thursday, September 6, 2018 at 10:00 a.m. Eastern Time in New York,
NY. Dr. Hoffman will provide a corporate overview and business update.

The presentation will be webcast live and may be accessed by visiting
Aerpio's website at http://ir.aerpio.com/.

About Aerpio Pharmaceuticals

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on
advancing first-in-class treatments for ocular diseases. The Company's
lead compound, AKB-9778, is a small molecule activator of the Tie2
pathway and is in clinical development for the treatment of
non-proliferative diabetic retinopathy. For more information, please
visit www.aerpio.com.

View Comments and Join the Discussion!